Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT07365839
What this trial is testing

Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Virginia Commonwealth University
Large-scale testing (Phase 3)Not Yet RecruitingNCT07309419
What this trial is testing

A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 222
Testing effectiveness (Phase 2)Study completedNCT03535259
What this trial is testing

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, Radiotherapy, Sorafenib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 86
Not applicableStudy completedNCT04975932
What this trial is testing

Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 826
Testing effectiveness (Phase 2)Study completedNCT00058487
What this trial is testing

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Dana-Farber Cancer Institute 12
Early research (Phase 1)Looking for participantsNCT06363006
What this trial is testing

Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 40
Not applicableUnknownNCT03110055
What this trial is testing

The Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC.

Who this might be right for
HCV, HCC
Tel-Aviv Sourasky Medical Center 20
Not applicableLooking for participantsNCT07159048
What this trial is testing

The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors

Who this might be right for
Hepatocellular CarcinomaColorectal Cancer Liver Metastasis
Fudan University 120
Testing effectiveness (Phase 2)Study completedNCT00559455
What this trial is testing

Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Sanofi 38
Not applicableStudy completedNCT01896778
What this trial is testing

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Who this might be right for
Adult Liver CarcinomaBreast CarcinomaColon Carcinoma+7 more
Roswell Park Cancer Institute 9
Not applicableUnknownNCT01247506
What this trial is testing

Different Genetic Features Associated With Hepatic Carcinogenesis

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 160
Not applicableStudy completedNCT04823715
What this trial is testing

Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW Comparison

Who this might be right for
Non-metastatic Hepatocellular Carcinoma
Hospices Civils de Lyon 163
Not applicableStudy completedNCT01137084
What this trial is testing

Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids

Who this might be right for
ImmunosuppressionHepatocellular CarcinomaLiver Transplantation+1 more
Shanghai Jiao Tong University School of Medicine 300
Not applicableStudy completedNCT01320852
What this trial is testing

PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
McGill University Health Centre/Research Institute of the McGill University Health Centre 100
Testing effectiveness (Phase 2)UnknownNCT04443309
What this trial is testing

Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 53
Not applicableStudy completedNCT02693847
What this trial is testing

Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaHIV+1 more
Hospital Universitario de Valme 446
Testing effectiveness (Phase 2)Ended earlyNCT02821533
What this trial is testing

Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 24
Not applicableStudy completedNCT02730611
What this trial is testing

Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma

Who this might be right for
Morbid ObesityVertical Sleeve GastrectomyMetabolic Syndrome+3 more
Assistance Publique - Hôpitaux de Paris 124
Testing effectiveness (Phase 2)Study completedNCT00576199
What this trial is testing

Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer

Who this might be right for
Liver Cancer
Hoffmann-La Roche 30
Early research (Phase 1)Active Not RecruitingNCT03264664
What this trial is testing

Study of E7386 in Participants With Selected Advanced Neoplasms

Who this might be right for
Advanced Neoplasms
Eisai Inc. 60
Next Page